What is NDC 42708-082?

42708-082 is the product NDC for Benzonatate, Benzonatate 200 mg/1 capsule, listed with the FDA by QPharma, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

QPharma, Inc., NDC labeler code 42708. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Benzonatate?

134 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Benzonatate NDC 42708-082 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)42708-082Labeler and product segments. Claims need a package NDC.

Product NDC at billing width42708-0082Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
42708-082-21	4270800822142708008221	21 CAPSULE in 1 BOTTLE (42708-082-21)Marketed from Feb 28, 2019 · Sample package

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Benzonatate
Generic name (nonproprietary): benzonatate
Active ingredients: Benzonatate — 200 mg/1
Dosage form: Capsule
Route: Oral
Labeler: QPharma, Inc.NDC labeler code 42708
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040627
Marketing start: Mar 22, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Tracheobronchial Stretch Receptor Activity (Physiologic effect)
Identifiers: Product ID 42708-082_4682a652-1196-5854-e063-6394a90a4c30SPL ID 4682a652-1196-5854-e063-6394a90a4c30SPL set ID 55c4ae18-3e37-4caf-9fdb-9d307970b5f9RxCUI 283417UNII 5P4DHS6ENR
Pharmacologic class: Non-narcotic Antitussive

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N442708008221 followed by a unit qualifier and the quantity

Package 42708-0082-21. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 21, 2025.

Indications (excerpt from the label)

INDICATIONS & USAGE Benzonatate USP is indicated for the symptomatic relief of cough.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 42708-082

What is NDC 42708-082?: 42708-082 is the product NDC for Benzonatate, Benzonatate 200 mg/1 capsule, listed with the FDA by QPharma, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Benzonatate.
What is the active ingredient?: Benzonatate.
Who is the labeler?: QPharma, Inc., NDC labeler code 42708. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Benzonatate?: 134 other product NDCs are listed under this name. See all Benzonatate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Benzonatate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Benzonatate	Benzonatate 100 mg/1	CapsuleOral	Strides Pharma Science Limited	64380-712	64380-0712-0664380-0712-07
Benzonatate	Benzonatate 200 mg/1	CapsuleOral	Strides Pharma Science Limited	64380-713	64380-0713-0664380-0713-07
Benzonatate	Benzonatate 150 mg/1	CapsuleOral	Anvi Pharmaceuticals Inc	87519-111	87519-0111-90
Benzonatate	Benzonatate 100 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4558	70518-4558-0070518-4558-0170518-4558-02+1 more
Benzonatate	Benzonatate 100 mg/1	CapsuleOral	Coupler LLC	67046-1629	67046-1629-03
Benzonatate	Benzonatate 200 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4497	70518-4497-0070518-4497-01
Benzonatate	Benzonatate 100 mg/1	CapsuleOral	St. Mary's Medical Park Pharmacy	60760-869	60760-0869-1560760-0869-30
Benzonatate	Benzonatate 100 mg/1	CapsuleOral	Coupler LLC	67046-1484	67046-1484-03
Benzonatate	Benzonatate 200 mg/1	CapsuleOral	Direct_rx	72189-606	72189-0606-2072189-0606-30
Benzonatate	Benzonatate 100 mg/1	Capsule, Liquid filledOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-898	23155-0898-0123155-0898-05

All 135 Benzonatate NDCs

Other NDCs under ANDA 040627

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 040627
Product	Strength	Form · route	Labeler	Product NDC
benzonatate	Benzonatate 100 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-1329
benzonatate	Benzonatate 100 mg/1	CapsuleOral	Proficient Rx LP	71205-971
Benzonatate	Benzonatate 100 mg/1	CapsuleOral	Ascend Laboratories, LLC	67877-573
Benzonatate	Benzonatate 200 mg/1	CapsuleOral	Ascend Laboratories, LLC	67877-575
Benzonatate	Benzonatate 200 mg/1	CapsuleOral	Northwind Health Company, LLC	51655-776
Benzonatate	Benzonatate 100 mg/1	CapsuleOral	Coupler LLC	67046-1629
benzonatate	Benzonatate 100 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-0688
benzonatate	Benzonatate 100 mg/1	CapsuleOral	Proficient Rx LP	63187-928